Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APEX-STROKE: Adaptive Platform Trial in Stroke
NCT07784569Phase 3Not yet recruiting
- Sponsor
- Fudan University
- Start
- Sep 2026
- Primary completion
- Jun 2029
01
Overview
A Phase 3 trial of Angong Niuhuang Pill, Yiqi Huayu Jiedu Mixture in stroke, sponsored by Fudan University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Angong Niuhuang PillYiqi Huayu Jiedu Mixture
03
Conditions
stroke
Beyond the preview
Go deeper on NCT07784569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07784569.